Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0MC5O
|
|||
| Former ID |
DIB004734
|
|||
| Drug Name |
CAP-1002
|
|||
| Indication | Duchenne dystrophy [ICD-11: 8C70; ICD-10: G71.0] | Phase 2 | [1] | |
| Myocardial infarction [ICD-11: BA41-BA43; ICD-9: 410] | Phase 1/2 | [2] | ||
| Company |
Capricor
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT03406780) A Study of CAP-1002 in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy (HOPE-2). U.S. National Institutes of Health. | |||
| REF 2 | ClinicalTrials.gov (NCT02485938) HOPE-Duchenne (Halt cardiomyOPathy progrEssion in Duchenne). | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.